MedPath

Socket Preservation Using Autogenous Bone Graft Versus MPM

Phase 1
Conditions
Bone Graft; Complications
Interventions
Other: MPM(Mineralized plasmatic matrix).
Other: Autogenous Bone Graft
Registration Number
NCT03008538
Lead Sponsor
Cairo University
Brief Summary

Studying the comparative effectiveness of socket preservation using autogenous bone graft versus MPM for implant insertion.

Detailed Description

To assess bone quality, stability of implants placed in fresh extraction sockets of mandibular anterior and premorals augmented by MPM (Mineralized Plasmatic Matrix) versus autogenous bone graft (gold standard), at different follow-up periods (0, 3, 6, 9 months).

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  1. Medically free patients.
  2. Patients with mandibular anterior and premolar hopeless teeth indicated for extraction.
  3. Evaluated bone height on X.Ray to be (0-4 mm buccal bone dehiscence).
  4. Age between 18 and 40 years.
  5. Both sexes.
  6. Patients physically able to tolerate surgical and restorative procedures. Good oral hygiene.
  7. Highly motivated patients.

Exclusion criteria:

  1. Smokers.
  2. Pregnant or lactating females.
  3. Presence of any pathosis in the pre-implant site.
  4. Presence of Para functional habits.
  5. History of oral radiotherapy.
  6. History of prolonged steroids use
  7. Psychological disorders.
Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Mineralized Plasmatic MatrixMPM(Mineralized plasmatic matrix).MPM(Mineralized plasmatic matrix) insertion in extraction sockets for socket preservation for later implant placement and histomorphometric analysis.
Autogenous Bone Graft (Gold Standards).Autogenous Bone GraftSocket preservation using Autogenous bone graft for later implant placement and histomorphometric analysis.
Primary Outcome Measures
NameTimeMethod
Patient Satisfaction regarding function, to be measured using patient questionnaire.3 Months.
Secondary Outcome Measures
NameTimeMethod
Comparative histomorphometric analysis, to be measured using a digital software called (leica QWin 500) and unit of measurements are to be (Pixels).3 Months.
© Copyright 2025. All Rights Reserved by MedPath